BioSpace News Archive

Business

Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related Lymphoma

Trial will replace currently used chemotherapy conditioning with apamistamab-I-131, Actinium’s targeted conditioning ARC, to selectively eliminate lymphoma cancer cells and stem cells to enable engraftment of stem cell gene therapy

January 13, 2020
·
10 min read
Genetown

First Japanese Patients Randomized In Corvia Medical’s REDUCE LAP-HF II Global Clinical Trial For Heart Failure

Corvia Medical, Inc. announced the first Japanese patients were randomized in Toyama and Hyogo under a clinical trial authorization from the Pharmaceutical and Medical Device Agency in the REDUCE LAP-HF II trial.

January 13, 2020
·
5 min read
Job Trends

TriSalus™ Life Sciences Launches the new TriNav™ Infusion System, an Innovative Solution Designed to Overcome Infusion Barriers within Solid Tumors

TriSalusTM Life Sciences (“TriSalus”), a company committed to transforming outcomes for patients with solid tumors, today announced the launch of its TriNav™ Infusion System (“TriNav”).

January 13, 2020
·
6 min read
Business

Pear Therapeutics Announces Collaboration with Apricity Health to Advance Prescription Digital Therapeutics to be Prescribed in Combination with Immuno-oncology Therapy

Pear Therapeutics, Inc. the leader in Prescription Digital Therapeutics (PDTs), announced today that it has entered into an agreement with Apricity Health, LLC to develop up to two product candidates for precision management of patients undergoing cancer treatment.

January 13, 2020
·
3 min read
Business

Foundation Medicine Appoints Ritesh Khullar as Chief Commercial Officer

Oncology industry veteran to lead product sales and operations efforts

January 13, 2020
·
2 min read
Genetown

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

KalVista Pharmaceuticals, Inc. provided an update on its franchise of oral plasma kallikrein inhibitors for treatment of hereditary angioedema.

January 13, 2020
·
4 min read
Business

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2019 Revenue Results

Apyx Medical Corporation reported preliminary revenue results for the full year and fourth quarter ended December 31, 2019.

January 13, 2020
·
5 min read
Business

Intersect ENT Reports Preliminary Full Year 2019 Revenue

Intersect ENT, Inc. (NASDAQ: XENT), a company transforming care for patients with ear, nose and throat conditions, today reported preliminary unaudited revenue for the full year ended December 31, 2019.

January 13, 2020
·
2 min read
Business

Antibe Therapeutics Expands Executive Team in Preparation for Large Market Partnering

The creation of this position represents a further step in the Company’s partnering efforts for its lead drug, ATB-346, and for our overall drug platform.

January 13, 2020
·
3 min read
Business

STAAR Surgical Reports Preliminary Fourth Quarter Net Sales Growth of 25%

Achieves 33% ICL Unit Growth for Fiscal 2019

January 13, 2020
·
5 min read